OOIR: Observatory of International Research

Papers

(The H4-Index of Hepatology Communications is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Issue Information	162
HBV DNA polymerase regulates tumor cell glycogen to enhance the malignancy of HCC cells	147
CD8 TRM-like T cells expressing perforin and IFN-γ define a pediatric activated T-cell acute liver failure endotype	110
Quality improvement in hepatology requires a chronic care framework	86
Association between widespread pain and associated symptoms in patients with cirrhosis	78
Clinical decision support automates care gap detection among primary care patients with nonalcoholic fatty liver disease	76
Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia	72
Immunologic landscape of human hepatic hemangiomas and epithelioid hemangioendotheliomas	67
Medical malpractice claims in Hepatology: Rates, Reasons, and Results	66
Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda	66
Pain in chronic liver disease compared to other chronic conditions: Results from a contemporary nationally representative cohort study	56
Visualizing in situ viral replication across the natural history of chronic HBV infection	56
The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?	54
Resolution of hepatic fibrosis after ZFN-mediated gene editing in the PiZ mouse model of human α1-antitrypsin deficiency	53
Development and evaluation of a virtual reality driving test for patients with cirrhosis	52
Zinc fingers and homeoboxes 2 is required for diethylnitrosamine‐induced liver tumor formation in C57BL/6 mice	51
Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH	50
Increasing nonalcoholic fatty liver disease–related mortality rates in the United States from 1999 to 2022	50
Targeting hepatocyte-specific SLC2A8 blocks hepatic steatosis and dissociates TCA cycle flux inhibition from glutamine anaplerosis	50
Community-level social vulnerability and individual socioeconomic status on liver transplant referral outcome	48
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants	47
Mesenchymal stem/stromal cells armored by FGF21 ameliorate alcohol-induced liver injury through modulating polarization of macrophages	47
A genetic variant in the CD40 gene is related to HBV infection in the Chinese Han population	47
Effect of glucagon-like peptide-1 receptor agonists on histologic MASH: A meta-analysis of randomized controlled trials	46
Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease	46

Aramchol attenuates fibrosis in mouse models of biliary fibrosis and blocks the TGFβ-induced fibroinflammatory mediators in cholangiocytes	46
Granulomatous liver diseases	46
Progression of MASH to cirrhosis, decompensation, and mortality, and the utility of NITs for detection and risk stratification	45
Disproportionate increases in alcohol-associated hepatitis incidence in women and individuals of low socioeconomic status: A population-based study using the Rochester epidemiology project database	45
Noninvasive pathway for stratifying fibrosis in suspected metabolic dysfunction and alcohol-associated liver disease (MetALD)	43
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial	41
Erratum: Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: Data from the GLIMMER study	41
Copper deficiency is an independent risk factor for mortality in patients with advanced liver disease	40
Depression and anxiety management in cirrhosis	40
Complementary and alternative medicines and liver disease	39
Management of alcohol withdrawal syndrome in patients with alcohol-associated liver disease	38
Reduced short-term survival following liver transplant in patients with acute-on-chronic liver failure: Reevaluating OPTN data	38
High prevalence of liver fibrosis among general population: a Romanian population-based study: Erratum	38
Letter to the Editor: Rifamycin SV MMX was superior to placebo, but was the comparison appropriate?	38